<< Savvis incorporates Vitality's wellness program to help improve employees’ health challenges | Online self-assessment tool on MayoClinic.com helps assess flu symptoms >>
Read in | English | Italiano | 繁體中文 | Dansk | Nederlands | Filipino | Svenska

Oral contraceptives may have a potential role in the management of premenopausal women with asthma

Published on November 5, 2009 at 1:09 AM · No Comments

New research shows that during natural menstrual cycles, women with asthma who were not taking oral contraceptives (OC) had lower exhaled nitric oxide levels (eNO), a marker of airway inflammation associated with asthma, than women who were taking OC.

Researchers from McMaster University in Hamilton, ON, Canada, studied 17 women with asthma during their menstrual cycles. Results showed that individuals not using oral contraceptives (OC) had higher mean eNO levels than women using OC.

Furthermore, among women not using oral contraceptives, an increase in estrogen levels was associated with a decrease in eNO, while an increase in progesterone was significantly associated with an increase in eNO. Researchers speculate that OC may have a potential role in the management of premenopausal women with asthma.

This article is published in the November issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians.

Source: American College of Chest Physicians

Posted in: Medical Condition News | Women's Health News

Tags: , , , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading